Sanofi SNY
NASDAQ SNY
$42.48 -0.66 (-1.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Sanofi (SNY) Dividends Paid - Common (2009 - 2026)

Sanofi's (SNY) quarterly Dividends Paid - Common came in at $6.1 billion in Q2 2026, up 14.71% year-over-year from $5.3 billion in Q2 2025, and up 1746.04% quarter-over-quarter from -$370.0 million in Q1 2026.

Analysis

Sanofi (SNY) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Sanofi has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $6.1 billion for Q2 2026.

  • In Q2 2026, Dividends Paid - Common rose 14.71% year-over-year to $6.1 billion; the TTM figure through Jun 2026 stood at -$11.0 billion (down 130.45% YoY), while the FY2025 annual figure was $2.4 billion, down 53.72% from the prior year.
  • Dividends Paid - Common came in at $6.1 billion for Q2 2026 at Sanofi, up from -$370.0 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $6.1 billion in Q2 2026 to a low of -$11.2 billion in Q3 2025.
  • Average Dividends Paid - Common over 5 years is -$2.7 billion, with a median of -$4.8 billion recorded in 2023.
  • The largest YoY upside for Dividends Paid - Common was 14.71% in 2026 against a maximum downside of 528.91% in 2026.
  • Over 5 years, Dividends Paid - Common stood at -$4.3 billion in 2022, then retreated by 12.7% to -$4.8 billion in 2023, then declined by 4.89% to -$5.0 billion in 2024, then declined by 10.51% to -$5.6 billion in 2025, then soared by 209.63% to $6.1 billion in 2026.
  • Per Business Quant data, the three most recent Dividends Paid - Common figures were $6.1 billion in Q2 2026, -$370.0 million in Q1 2026, and -$5.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 3.23 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.07 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.87 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.45 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 1.29 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 6.09 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.09 Bn
Mar 31, 2026 -369.96 Mn
Dec 31, 2025 -5.55 Bn
Sep 30, 2025 -11.16 Bn
Jun 30, 2025 5.31 Bn
Mar 31, 2025 86.25 Mn
Dec 31, 2024 -5.03 Bn
Sep 30, 2024 -5.14 Bn
Dec 31, 2023 -4.79 Bn
Sep 30, 2023 -4.80 Bn
Dec 31, 2022 -4.25 Bn
Dec 31, 2021 -4.59 Bn
Dec 31, 2020 -4.69 Bn
Dec 31, 2019 -4.24 Bn
Dec 31, 2018 -4.31 Bn
Dec 31, 2017 -4.37 Bn
Dec 31, 2016 -4.06 Bn
Dec 31, 2015 -4.05 Bn
Dec 31, 2014 -4.59 Bn
Dec 31, 2013 4.95 Bn